Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A E Chang

Showing results (71-80 of 154) with videos related to

Pageof 16
Sort By:
Journal of the American Academy of Dermatology|May 20, 1998
Advances in melanoma therapyT M Johnson, A M Yahanda, A E Chang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1987
Reduction of toxicity of interleukin-2 and lymphokine-activated killer cells in humans by the administration of corticosteroidsJ T Vetto, M Z Papa, M T Lotze, et al.
Cancer Research|March 1, 1993
Clinical observations on adoptive immunotherapy with vaccine-primed T-lymphocytes secondarily sensitized to tumor in vitroA E Chang, H Yoshizawa, K Sakai, et al.
Archives of Dermatology|November 14, 2000
Solitary melanoma confined to the dermal and/or subcutaneous tissue: evidence for revisiting the staging classificationG M Bowen, A E Chang, L Lowe, et al.
Journal of the American College of Surgeons|February 1, 1995
Immediate transverse rectus abdominis musculocutaneous flap reconstruction after mastectomyE G Wilkins, D A August, W M Kuzon, et al.
Radiology|December 9, 1998
Mammographic appearance of recurrent breast carcinoma in six patients with TRAM flap breast reconstructionsM A Helvie, T E Wilson, M A Roubidoux, et al.
Journal of Immunopharmacology|January 1, 1985
A large scale method of separating multiple lymphokines secreted by the murine EL-4 thymomaA E Chang, M T Lotze, R S Ames, et al.
Archives of Dermatology|December 1, 1988
Interleukin 2 and psoriasisR E Lee, A A Gaspari, M T Lotze, et al.
Cancer Immunology, Immunotherapy : CII|May 1, 1996
Diverse manifestations of tumorigenicity and immunogenicity displayed by the poorly immunogenic B16-BL6 melanoma transduced with cytokine genesM J Arca, J C Krauss, S E Strome, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|July 1, 1994
Effect of interleukin-1 alpha on the in vitro activation of tumor-draining lymph node cells for adoptive immunotherapyJ M Hammel, M K Tuck, J M Hain, et al.
Pageof 16

Showing results (71-80 of 154) with videos related to

Sort By:
Pageof 16
Journal of the American Academy of Dermatology|May 20, 1998
Advances in melanoma therapyT M Johnson, A M Yahanda, A E Chang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1987
Reduction of toxicity of interleukin-2 and lymphokine-activated killer cells in humans by the administration of corticosteroidsJ T Vetto, M Z Papa, M T Lotze, et al.
Cancer Research|March 1, 1993
Clinical observations on adoptive immunotherapy with vaccine-primed T-lymphocytes secondarily sensitized to tumor in vitroA E Chang, H Yoshizawa, K Sakai, et al.
Archives of Dermatology|November 14, 2000
Solitary melanoma confined to the dermal and/or subcutaneous tissue: evidence for revisiting the staging classificationG M Bowen, A E Chang, L Lowe, et al.
Journal of the American College of Surgeons|February 1, 1995
Immediate transverse rectus abdominis musculocutaneous flap reconstruction after mastectomyE G Wilkins, D A August, W M Kuzon, et al.
Radiology|December 9, 1998
Mammographic appearance of recurrent breast carcinoma in six patients with TRAM flap breast reconstructionsM A Helvie, T E Wilson, M A Roubidoux, et al.
Journal of Immunopharmacology|January 1, 1985
A large scale method of separating multiple lymphokines secreted by the murine EL-4 thymomaA E Chang, M T Lotze, R S Ames, et al.
Archives of Dermatology|December 1, 1988
Interleukin 2 and psoriasisR E Lee, A A Gaspari, M T Lotze, et al.
Cancer Immunology, Immunotherapy : CII|May 1, 1996
Diverse manifestations of tumorigenicity and immunogenicity displayed by the poorly immunogenic B16-BL6 melanoma transduced with cytokine genesM J Arca, J C Krauss, S E Strome, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|July 1, 1994
Effect of interleukin-1 alpha on the in vitro activation of tumor-draining lymph node cells for adoptive immunotherapyJ M Hammel, M K Tuck, J M Hain, et al.
Pageof 16